甘精胰岛素联合那格列奈与胰岛素泵对2型糖尿病骨折患者围手术期的疗效观察  

Comparison of the therapeutic effects between insulin glargine combined with nateglinide and continuous subcutaneous insulin infusion during intraoperative period in type 2 diabetic patients with fracture

作　　者：卢昉[1] 魏爱生[1] 陈苹[1] 叶建红[1] 王甫能[1] 刘天[1] 吕丽雪[1] 郎江明[1] 

机构地区：[1]广州中医药大学附属佛山中医院糖尿病强,佛山528000

出　　处：《中华内分泌代谢杂志》2010年第2期127-129,共3页Chinese Journal of Endocrinology and Metabolism

摘　　要：分析甘精胰岛素联合那格列奈和胰岛素泵治疗2型糖尿病骨折患者围手术期的资料，发现两种治疗均能使血糖达标[空腹血糖（6．89±1．96）对（6．75±2．33）mmol／L]，达标时间无显著差异[（3．6±1．6）对（2．9±1．2）d，均P〉0．05]，但胰岛素泵组的平均血糖值更低。To compare the effect of insulin glargine combined with nateglinide and continuous subcutaneous insulin infusion（CSII） during intraoperative period in type 2 diabetic patients with fracture. Both of the managements made blood glucose under control [ fasting blood glucose （ 6.89±1.96 ） vs （ 6.75 ±2.33 ） mmol/L ] in similar period [ （ 3.6±1.6 ） vs （ 2.9 ± 1.2 ） d, both P〉0.05 ]. The mean blood glucose was lower in patients treated by CSII than that of the other group.

关 键 词：甘精胰岛素 那格列奈 持续性皮下胰岛素输注 糖尿病 2型 骨折 

分 类 号：R587.1[医药卫生—内分泌]